Changzhou Le Sun Pharmaceuticals Co., Ltd.-News & Events

News & Events

넳 넲

In March 2024, the mid-term analysis seminar of the phase II clinical trial of Sunaciclib (QHRD107) capsule was successfully held

넶0 2024-03-18
In November 2023, Auceliciclib (QHRD110) capsules were approved to conduct Phase I clinical research

넶1 2023-12-29
In December 2022, Sunaciclib capsules completed phase I clinical trials

넶1 2023-12-29
In December 2012, Changzhou High-tech Venture Capital Co., Ltd. expanded its capital and shares and settled in Lesun Pharma

넶0 2022-08-19